Cite
HARVARD Citation
Natali, A. et al. (2019). Metformin is the key factor in elevated plasma growth differentiation factor‐15 levels in type 2 diabetes: A nested, case–control study. Diabetes, obesity & metabolism. 21 (2), pp. 412-416. [Online].